Caspases shutdown nonsense-mediated mRNA decay during apoptosis

Archive ouverte

Jia, Jieshuang | Furlan, Alessandro | Gonzalez-Hilarion, Sara | Leroy, Catherine | Gruenert, Dieter | Tulasne, David | Lejeune, Fabrice

Edité par CCSD ; Nature Publishing Group -

International audience. Nonsense-mediated mRNA decay (NMD) is an mRNA surveillance mechanism that plays integral roles in eliminating mRNAs with premature termination codons to prevent the synthesis of truncated proteins that could be pathogenic. One response to the accumulation of detrimental proteins is apoptosis, which involves the activation of enzymatic pathways leading to protein and nucleic acid cleavage and culminating in cell death. It is not clear whether NMD is required to ensure the accurate expression of apoptosis genes or is no longer necessary since cytotoxic proteins are not an issue during cell death. The present study shows that caspases cleave the two NMD factors UPF1 and UPF2 during apoptosis impairing NMD. Our results demonstrate a new regulatory pathway for NMD that occurs during apoptosis and provide evidence for role of the UPF cleaved fragments in apoptosis and NMD inhibition.

Suggestions

Du même auteur

PTC readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins

Archive ouverte | Jia, Jieshuang | CCSD

International audience. Nonsense-mutation-containing messenger ribonucleoprotein particles (mRNPs) transit through cytoplasmic foci called P-bodies before undergoing nonsense-mediated mRNA decay (NMD), a cytoplasmic...

Rescue of nonsense mutations by amlexanox in human cells.

Archive ouverte | Gonzalez-Hilarion, Sara | CCSD

International audience. ABSTRACT: BACKGROUND: Nonsense mutations are at the origin of many cancers and inherited genetic diseases. The consequence of nonsense mutations is often the absence of mutant gene expression...

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases

Archive ouverte | Benhabiles, Hana | CCSD

International audience. About 10% of patients with a genetic disease carry a nonsense mutation causing their pathology. A strategy for correcting nonsense mutations is premature termination codon (PTC) readthrough, ...

Chargement des enrichissements...